Hypha Labs, Inc. dismissed Fruci & Associates II, PLLC as its auditor.
“and (ii) the dismissal of Fruci & Associates II, PLLC (“Fruci”), the Company’s current independent registered public accounting firm.”
Source-grounded facts extracted from Hypha Labs, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Hypha Labs, Inc. dismissed Fruci & Associates II, PLLC as its auditor.
“and (ii) the dismissal of Fruci & Associates II, PLLC (“Fruci”), the Company’s current independent registered public accounting firm.”
Hypha Labs, Inc. engaged Astra Audit and Advisory, LLC as its auditor.
“anuary 27, 2026, the Board approved: (i) the engagement of Astra Audit and Advisory, LLC (“Astra”) as the Company’s independent registered public accounting firm for the Company’s fiscal year ending September 30, 2026; and (ii) the dismissal of”
Hypha Labs, Inc.: Adopted a new Code of Conduct and Business Ethics (effective 2025-01-24).
“Effective January 24, 2025, the Company adopted a new Code of Conduct and Business Ethics (the “Code”), which applies to all directors, officers and employees of the Company and its subsidiaries.”
Hypha Labs, Inc.: Increased authorized common stock from 250,000,000 to 880,000,000 shares and preferred stock from 10,000,000 to 70,000,000 shares (effective 2025-01-15).
“Hypha Labs, Inc. (the “Company”) filed with the Secretary of State of Nevada a Certificate of Amendment to the Articles of Incorporation of the Company (the “Certificate of Amendment”), which increased (1) the authorized number of shares of common stock of the Company from 250,000,000 shares to 880,000,000 shares, and (2) the authorized number of shares of preferred stock of the Company from 10,000,000 shares to 70,000,000 shares. The Certificate of Amendment became effective on January 15, 2025.”
Hypha Labs, Inc.: Changed name from Digipath, Inc. to Hypha Labs, Inc (effective 2024-03-12).
“Effective March 12, 2024, Digipath, Inc., a Nevada corporation now known as Hypha Labs, Inc. (the “Company”), amended Article 1 of its Articles of Incorporation to change its name from Digipath, Inc. to Hypha Labs, Inc.”
A. Stone Douglass was appointed as President and Chief Executive Officer at Hypha Labs, Inc..
“The Company appointed A. Stone Douglass, the current Chairman, Chief Financial Officer and Secretary as well as a Director of the Company, to the additional roles of President and Chief Executive Officer of the Company effective February 29, 2024.”
Todd Denkin resigned as President at Hypha Labs, Inc..
“On February 28, 2024, Todd Denkin resigned his positions as President of Digipath, Inc. (the “Company”) and its wholly-owned subsidiary, Digipath Labs, Inc., effective the close of business on the same date to pursue other professional opportunities.”
Hypha Labs, Inc. completed a disposition involving DPL NV LLC for $2,300,000 (closed 2024-02-20).
“DPL NV LLC, a Nevada limited liability company (“Buyer”), pursuant to which Digipath Labs agreed to sell substantially all of its assets to Buyer for a cash purchase price of $2,300,000 (the “Purchase Price”). The Purchase Price was subject to adjustments at closing based on, among other things, the amount by which the working capital of Digipath Labs at the”
Hypha Labs, Inc. dismissed M&K CPAS, PLLC as its auditor.
“on September 27, 2023, the Board approved: (i) the engagement of Fruci & Associates II, PLLC (“ Fruci ”) as the Company’s independent registered public accounting firm for the Company’s fiscal year ending September 30, 2023; and (ii) the dismissal of M&K CPAS, PLLC”
Hypha Labs, Inc. engaged Fruci & Associates II, PLLC as its auditor.
“on September 27, 2023, the Board approved: (i) the engagement of Fruci & Associates II, PLLC (“ Fruci ”) as the Company’s independent registered public accounting firm”
Hypha Labs, Inc. entered into Asset Purchase Agreement with DPL NV, LLC valued at cash purchase price of $2,300,000 (effective 2022-04-20).
“On April 20, 2022, Digipath, Inc. (“the “Company”), and Digipath Labs, Inc. (“Digipath Labs”), a wholly-owned subsidiary of the Company, entered into an Asset Purchase Agreement (the “Purchase Agreement”) with DPL NV, LLC (“Buyer”), pursuant to which Digipath Labs has agreed to sell substantially all of its assets to Buyer for a cash purchase price of $2,300,000”
Bruce Raben resigned as director at Hypha Labs, Inc..
“On May 2, 2023, Bruce Raben submitted a letter to the Company resigning from his position as a director of the Company.”
A. Stone Douglass was appointed as Chief Financial Officer at Hypha Labs, Inc..
“On August 16, 2021, A. Stone Douglass, 74, who has served as a member of the Board of Directors (the “Board”) of Digipath, Inc. (the “Company”) since July 1, 2021, was appointed to serve as the Company’s Chief Financial Officer.”
Todd Denkin was appointed as President at Hypha Labs, Inc..
“On July 1, 2021, the Board appointed Todd Denkin to serve as the President of the Company.”
A. Stone Douglass was appointed as Board of Directors at Hypha Labs, Inc..
“On July 1, 2021, A. Stone Douglass, 73, was appointed to the Board of Directors (the “Board”) of Digipath, Inc. (the “Company”).”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.